Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DR

David Richard — 32 Patents

Pfizer: 10 patents #491 of 5,153Top 10%
FTForma Therapeutics: 8 patents #34 of 86Top 40%
NANovo Nordisk Health Care Ag: 6 patents #7 of 131Top 6%
EPEutropics Pharmaceuticals: 4 patents #2 of 7Top 30%
VDValo Early Discovery: 2 patents #20 of 30Top 70%
VHValo Health: 2 patents #35 of 53Top 70%
Littleton, MA: #10 of 347 inventorsTop 3%
Massachusetts: #2,824 of 88,656 inventorsTop 4%
Overall (All Time): #110,428 of 4,157,543Top 3%
32 Patents All Time
David Richard has been granted 32 US patents while listed as an inventor at Pfizer. The first was granted in 2011 and the most recent in March 2025. David Richard ranks #110,428 of 4,157,543 US inventors in our database (top 2.7%). Patent records list David Richard in Littleton, MA, US.

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12252490 Inhibiting deubiquitinase USP25 and USP28 David Joseph Guerin, Justin Andrew Caravella, Hongbin Li, Steven Mischke, Shawn Schiller +1 more 2025-03-18
12128035 Activating pyruvate kinase R Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Gary Marshall +7 more 2024-10-29 $114,666,000
12122778 Activating pyruvate kinase R Xiaozhang Zheng, Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr. +3 more 2024-10-22 $83,936,000
12071440 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Anna Ericsson, Neal Green, Gary Gustafson, Bingsong Han, David R. Lancia, Jr. +5 more 2024-08-27 $103,900,000
12053458 Treating sickle cell disease with a pyruvate kinase R activating compound Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Bingsong Han +5 more 2024-08-06 $208,108,000
11980611 Treating sickle cell disease with a pyruvate kinase R activating compound Anna Ericsson, Neal Green, Gary Gustafson, Bingsong Han, David R. Lancia, Jr. +5 more 2024-05-14 $216,614,000
11844787 Activating pyruvate kinase R Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Gary Marshall +2 more 2023-12-19
11814386 Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke +1 more 2023-11-14
11649242 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Anna Ericsson, Neal Green, Gary Gustafson, Bingsong Han, David R. Lancia, Jr. +5 more 2023-05-16
11535618 Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke +1 more 2022-12-27
11325917 Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2022-05-10
11247987 Inhibiting ubiquitin specific peptidase 30 Justin Andrew Caravella, Bingsong Han, Cuixian Liu, Stephanos Ioannidis, Alexandre Joseph Buckmelter +3 more 2022-02-15
11071725 Activating pyruvate kinase R Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Gary Marshall +2 more 2021-07-27
11014927 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Anna Ericsson, Neal Green, Gary Gustafson, Bingsong Han, David R. Lancia, Jr. +5 more 2021-05-25
11001588 Activating pyruvate kinase R and mutants thereof David R. Lancia, Jr., Gary Gustafson, Neal Green, Lorna Helen Mitchell, Anna Ericsson 2021-05-11
10913753 Thienopyridine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2021-02-09
10889592 Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2021-01-12
10765673 Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives Michael H. Cardone 2020-09-08
10675274 Activating pyruvate kinase R Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Gary Marshall +2 more 2020-06-09
10413549 Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivatives Michael H. Cardone 2019-09-17
10022381 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2018-07-17 $209,955,000
9345700 Compositions and methods useful for treating diseases Michael H. Cardone, Andrew Kolodziej 2016-05-24
9174963 Triazine compounds as PI3 kinase and MTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2015-11-03 $641,346,000
9051305 Compositions and methods useful for treating diseases Michael H. Cardone, Andrew Kolodziej 2015-06-09
8859542 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2014-10-14